Challenger engaging in talks with listed lenders and other potential partners amid push into private credit - Australian Financial Review (A$7.15, +0.05)
StreetAccount Sector Summary: Australian Financials Weekly Recap
StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday
Challenger reports Q3 AUM A$125.6B, (4%) q/q (A$6.17, 0.00)
StreetAccount Asia Macro Headlines
Challenger confirms Dai-ichi Life subsidiary to acquire 15.1% minority interest in Challenger from MS&AD for ¥763/sh (~A$8.46/sh) (A$5.54, 0.00)
MS&AD Insurance confirms sale of 15.1% stake in Challenger Limited to Dai-ichi Life Holdings subsidiary (A$5.54, 0.00)
Powered by FactSet Research Systems Inc.